| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | intracellular transport | CTAGE9 VPS37C MYH10 RBM33 EXPH5 SYNE1 MYRIP RHOT2 CTAGE6 INPP5F PHAX MDM2 EPS15L1 CCDC88A STX3 UBR5 CTAGE8 CTAGE15 RABGEF1 AKAP13 KIF5C CTAGE4 VAMP4 KPNB1 LARGE1 | 1.86e-06 | 1496 | 122 | 25 | GO:0046907 |
| GeneOntologyBiologicalProcess | vesicle cargo loading | 2.17e-06 | 36 | 122 | 5 | GO:0035459 | |
| GeneOntologyBiologicalProcess | protein secretion | CTAGE9 CACNA1D MYH10 SLC4A8 EXPH5 MYRIP CTAGE6 SIRT1 CASK CTAGE8 CTAGE15 CTAGE4 | 2.82e-05 | 480 | 122 | 12 | GO:0009306 |
| GeneOntologyBiologicalProcess | establishment of protein localization to extracellular region | CTAGE9 CACNA1D MYH10 SLC4A8 EXPH5 MYRIP CTAGE6 SIRT1 CASK CTAGE8 CTAGE15 CTAGE4 | 2.99e-05 | 483 | 122 | 12 | GO:0035592 |
| GeneOntologyBiologicalProcess | protein localization to extracellular region | CTAGE9 CACNA1D MYH10 SLC4A8 EXPH5 MYRIP CTAGE6 SIRT1 CASK CTAGE8 CTAGE15 CTAGE4 | 3.44e-05 | 490 | 122 | 12 | GO:0071692 |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 4.64e-06 | 42 | 123 | 5 | GO:0070971 | |
| GeneOntologyCellularComponent | myosin II filament | 1.03e-04 | 3 | 123 | 2 | GO:0097513 | |
| GeneOntologyCellularComponent | dendrite | CACNA1D MYH10 SLC4A8 SYNE1 PPFIA1 INPP5F TENM2 CASK STX3 SACS EIF4B LRP4 RABGEF1 TRPM1 KIF5C | 1.58e-04 | 858 | 123 | 15 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CACNA1D MYH10 SLC4A8 SYNE1 PPFIA1 INPP5F TENM2 CASK STX3 SACS EIF4B LRP4 RABGEF1 TRPM1 KIF5C | 1.62e-04 | 860 | 123 | 15 | GO:0097447 |
| GeneOntologyCellularComponent | axon | MAP9 MYH10 IL31RA SLC4A8 PPFIA1 ITGA2 INPP5F TENM2 SIRT1 STX3 SACS MYH14 UNC13C TRPM1 KIF5C | 2.37e-04 | 891 | 123 | 15 | GO:0030424 |
| GeneOntologyCellularComponent | contractile actin filament bundle | 4.28e-04 | 107 | 123 | 5 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 4.28e-04 | 107 | 123 | 5 | GO:0001725 | |
| GeneOntologyCellularComponent | neuromuscular junction | 5.28e-04 | 112 | 123 | 5 | GO:0031594 | |
| GeneOntologyCellularComponent | actomyosin | 6.44e-04 | 117 | 123 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 6.69e-04 | 118 | 123 | 5 | GO:0032432 | |
| GeneOntologyCellularComponent | site of polarized growth | 7.55e-04 | 253 | 123 | 7 | GO:0030427 | |
| GeneOntologyCellularComponent | distal axon | 1.10e-03 | 435 | 123 | 9 | GO:0150034 | |
| GeneOntologyCellularComponent | ciliary transition fiber | 1.50e-03 | 10 | 123 | 2 | GO:0097539 | |
| GeneOntologyCellularComponent | supramolecular fiber | CACNA1D MAP9 MYH10 KIF27 DNAH10 SYNE1 ODF2 RYR2 DLC1 MYH14 AKAP13 KIF5C SKA3 ARHGAP18 FERMT2 WDR44 | 1.51e-03 | 1179 | 123 | 16 | GO:0099512 |
| GeneOntologyCellularComponent | cell cortex | 1.60e-03 | 371 | 123 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | supramolecular polymer | CACNA1D MAP9 MYH10 KIF27 DNAH10 SYNE1 ODF2 RYR2 DLC1 MYH14 AKAP13 KIF5C SKA3 ARHGAP18 FERMT2 WDR44 | 1.62e-03 | 1187 | 123 | 16 | GO:0099081 |
| Pubmed | MAP9 MYH10 LEO1 SYNE1 PPFIA1 SIPA1L3 ASH1L MYRIP DNAJC21 CTAGE6 ZFC3H1 TEX14 ODF2 PALB2 RYR2 STX3 SACS MYH14 TCHHL1 EIF4B CTAGE8 CTAGE15 KMT2A KIF5C CTAGE4 EIF4G3 KPNB1 | 1.67e-12 | 1442 | 126 | 27 | 35575683 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | HIVEP1 EXPH5 PPFIA1 SIPA1L3 INPP5F DENND2B WWC2 PHLDB1 CCDC88A DLC1 EIF4B KMT2A RABGEF1 AKAP13 KIF5C SKA3 EIF4G3 GOLGA4 | 2.34e-09 | 861 | 126 | 18 | 36931259 |
| Pubmed | MYH10 HIVEP1 EXPH5 ASH1L LAMB2 RHOT2 DENND2B RYR2 CASK RLF UBR5 HTATSF1 RABGEF1 SPARCL1 KPNB1 | 4.33e-09 | 591 | 126 | 15 | 15231748 | |
| Pubmed | NOL4 HIVEP1 ZGRF1 PPFIA1 ZNF507 INPP5F ANKHD1 PALB2 RLF PRR12 CCDC88A UBR5 SKA3 | 4.54e-09 | 418 | 126 | 13 | 34709266 | |
| Pubmed | 2.97e-08 | 187 | 126 | 9 | 26460568 | ||
| Pubmed | MYT1L LEO1 SYNE1 SIPA1L3 ASH1L MYRIP ZFC3H1 ODF2 CASK EPS15L1 SACS MYH14 NMT2 ARL13B LRP4 YY1AP1 SPARCL1 KIF5C EIF4G3 KPNB1 | 3.99e-08 | 1285 | 126 | 20 | 35914814 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | HIVEP1 LEO1 ZNF507 RFC1 ODF2 PALB2 EMSY SIRT1 WWC2 EPS15L1 EIF4B KMT2A YY1AP1 GOLGA4 WDR44 | 1.49e-07 | 774 | 126 | 15 | 15302935 |
| Pubmed | NOL4 MYH10 HIVEP1 DNAH10 RBM33 FOS ZNF507 RHOT2 VSX1 RFC1 MDM2 ANKHD1 EMSY SIRT1 RLF PRR12 RNF214 MYH14 KMT2A YY1AP1 | 2.20e-07 | 1429 | 126 | 20 | 35140242 | |
| Pubmed | MYH10 HIVEP1 RBM33 EXPH5 FOS SYNE1 LAMB2 TTC1 CCDC88A AKAP13 YY1AP1 WDR44 | 2.24e-07 | 486 | 126 | 12 | 20936779 | |
| Pubmed | VWA8 SYNE1 PPFIA1 DNAJC21 ZFC3H1 TTC1 SIRT1 CASK FAM204A CCDC88A SACS UBR5 RWDD1 ARL13B HTATSF1 AKAP13 ELP2 EIF4G3 FERMT2 GOLGA4 | 4.13e-07 | 1487 | 126 | 20 | 33957083 | |
| Pubmed | SYNE1 ITGA2 INPP5F EPS15L1 CCDC88A ARL13B ARHGAP18 FERMT2 GOLGA4 WDR44 | 4.81e-07 | 339 | 126 | 10 | 37232246 | |
| Pubmed | 1.38e-06 | 23 | 126 | 4 | 17203973 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MYH10 RFC1 PHAX TTC1 ANKHD1 EMSY EPS15L1 EIF4B HTATSF1 KMT2A SKA3 EIF4G3 FERMT2 WDR44 KPNB1 | 1.57e-06 | 934 | 126 | 15 | 33916271 |
| Pubmed | MYH10 SLC4A8 SYNE1 PPFIA1 SIPA1L3 TENM2 EMSY CASK EPS15L1 CCDC88A UBR5 RABGEF1 KIF5C GOLGA4 KPNB1 | 2.28e-06 | 963 | 126 | 15 | 28671696 | |
| Pubmed | Redundant functions of RIM1alpha and RIM2alpha in Ca(2+)-triggered neurotransmitter release. | 2.31e-06 | 26 | 126 | 4 | 17124501 | |
| Pubmed | A Conserved Role for Girdin in Basal Body Positioning and Ciliogenesis. | 2.57e-06 | 8 | 126 | 3 | 27623382 | |
| Pubmed | CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis. | 2.57e-06 | 8 | 126 | 3 | 34145035 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MYH10 SIPA1L3 ZNF507 ODF2 TTC1 CEP164 EMSY EPS15L1 CCDC88A UBR5 EIF4B KIF5C FERMT2 KPNB1 | 2.79e-06 | 853 | 126 | 14 | 28718761 |
| Pubmed | MAP9 MYH10 SYNE1 PPFIA1 SIPA1L3 ITGA2 CASK EPS15L1 PHLDB1 SACS MYH14 NMT2 EIF4B KMT2A KIF5C EIF4G3 FERMT2 KPNB1 | 4.25e-06 | 1431 | 126 | 18 | 37142655 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 6.03e-06 | 123 | 126 | 6 | 26912792 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYH10 SIPA1L3 AFF3 ASH1L MYRIP DENND2B CASK RLF PKNOX2 EPS15L1 PHLDB1 STX3 ATP11B MYH14 AKAP13 KIF5C EIF4G3 GOLGA4 | 7.32e-06 | 1489 | 126 | 18 | 28611215 |
| Pubmed | RBM33 SYNE1 PPFIA1 SIPA1L3 DNAJC21 LAMB2 ZFC3H1 ODF2 ANKHD1 CEP164 EMSY CASK PRR12 JARID2 NMT2 EIF4B KMT2A EIF4G3 | 7.87e-06 | 1497 | 126 | 18 | 31527615 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 1.01e-05 | 377 | 126 | 9 | 38117590 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | HIVEP1 LEO1 RBM33 ZGRF1 ZNF507 MDM2 EMSY SIRT1 CCDC88A UBR5 YY1AP1 | 1.03e-05 | 588 | 126 | 11 | 38580884 |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 22025714 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 12743608 | ||
| Pubmed | Maurocalcin and its analog MCaE12A facilitate Ca2+ mobilization in cardiomyocytes. | 1.30e-05 | 2 | 126 | 2 | 33034621 | |
| Pubmed | LAF4, an AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia. | 1.30e-05 | 2 | 126 | 2 | 12203795 | |
| Pubmed | NAD(+)-SIRT1 control of H3K4 trimethylation through circadian deacetylation of MLL1. | 1.30e-05 | 2 | 126 | 2 | 25751424 | |
| Pubmed | Laminin stimulates and guides axonal outgrowth via growth cone myosin II activity. | 1.30e-05 | 2 | 126 | 2 | 15880105 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 18302019 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 20861308 | ||
| Pubmed | 1.60e-05 | 219 | 126 | 7 | 29997244 | ||
| Pubmed | 2.05e-05 | 15 | 126 | 3 | 19536649 | ||
| Pubmed | 2.51e-05 | 16 | 126 | 3 | 20301753 | ||
| Pubmed | 2.89e-05 | 162 | 126 | 6 | 15174051 | ||
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 2.99e-05 | 163 | 126 | 6 | 22113938 | |
| Pubmed | 3.32e-05 | 50 | 126 | 4 | 37974198 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | CTC1 PPFIA1 FLVCR2 ITGA2 MDM2 TENM2 PRR12 ATP11B EIF4G3 GOLGA4 | 3.48e-05 | 552 | 126 | 10 | 10737800 |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 25238203 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 20685736 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 15177565 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 31235574 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 14966118 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 37393374 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 15774463 | ||
| Pubmed | Transcriptional regulation of dentin matrix protein 1 (DMP1) by AP-1 (c-fos/c-jun) factors. | 3.90e-05 | 3 | 126 | 2 | 12489182 | |
| Pubmed | PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells. | 3.90e-05 | 3 | 126 | 2 | 23418787 | |
| Pubmed | Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family. | 3.90e-05 | 3 | 126 | 2 | 14594953 | |
| Pubmed | Identification of a membrane-less compartment regulating invadosome function and motility. | 3.90e-05 | 3 | 126 | 2 | 29348417 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 23585472 | ||
| Pubmed | Characterization of three full-length human nonmuscle myosin II paralogs. | 3.90e-05 | 3 | 126 | 2 | 24072716 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 15845534 | ||
| Pubmed | 4.16e-05 | 105 | 126 | 5 | 9628581 | ||
| Pubmed | 4.28e-05 | 453 | 126 | 9 | 29656893 | ||
| Pubmed | 4.31e-05 | 19 | 126 | 3 | 24421332 | ||
| Pubmed | PPFIA1 DNAJC21 RFC1 PHAX TTC1 RLF TRMT6 DLC1 UBR5 EIF4B QPCT UNC13C KPNB1 | 5.40e-05 | 971 | 126 | 13 | 33306668 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 5.41e-05 | 361 | 126 | 8 | 26167880 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | SYNE1 PPFIA1 SIPA1L3 RTTN EPS15L1 TRMT6 CCDC88A ATP11B UBR5 LRP4 GOLGA4 | 6.46e-05 | 719 | 126 | 11 | 35337019 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | RBM33 PPFIA1 DNAJC21 ZFC3H1 ANKHD1 RNF214 MYH14 EIF4B AKAP13 EIF4G3 FERMT2 | 6.87e-05 | 724 | 126 | 11 | 36232890 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | LEO1 PPFIA1 LAMB2 PHAX TTC1 SIRT1 EPS15L1 TRMT6 MYH14 EIF4B HTATSF1 RABGEF1 ELP2 FERMT2 WDR44 KPNB1 | 7.59e-05 | 1455 | 126 | 16 | 22863883 |
| Pubmed | Ten-m2 is required for the generation of binocular visual circuits. | 7.78e-05 | 4 | 126 | 2 | 23884953 | |
| Pubmed | A Designed Peptide Targets Two Types of Modifications of p53 with Anti-cancer Activity. | 7.78e-05 | 4 | 126 | 2 | 29681526 | |
| Pubmed | ARL13B, PDE6D, and CEP164 form a functional network for INPP5E ciliary targeting. | 7.78e-05 | 4 | 126 | 2 | 23150559 | |
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 18508042 | ||
| Pubmed | Mea6 controls VLDL transport through the coordinated regulation of COPII assembly. | 7.78e-05 | 4 | 126 | 2 | 27311593 | |
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 9645947 | ||
| Pubmed | Deletion of Mea6 in Cerebellar Granule Cells Impairs Synaptic Development and Motor Performance. | 7.78e-05 | 4 | 126 | 2 | 33718348 | |
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 12586826 | ||
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 32572902 | ||
| Pubmed | Cellular nonmuscle myosins NMHC-IIA and NMHC-IIB and vertebrate heart looping. | 7.78e-05 | 4 | 126 | 2 | 18697221 | |
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 31244610 | ||
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 35081333 | ||
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 21807889 | ||
| Pubmed | Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer. | 7.78e-05 | 4 | 126 | 2 | 26802432 | |
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 20042607 | ||
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 24982445 | ||
| Pubmed | 7.80e-05 | 23 | 126 | 3 | 20301575 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 7.87e-05 | 120 | 126 | 5 | 31413325 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 8.58e-05 | 197 | 126 | 6 | 20811636 | |
| Pubmed | 9.37e-05 | 65 | 126 | 4 | 23453885 | ||
| Pubmed | 9.84e-05 | 202 | 126 | 6 | 24639526 | ||
| Pubmed | 1.01e-04 | 25 | 126 | 3 | 29487109 | ||
| Pubmed | Centrosome anchoring regulates progenitor properties and cortical formation. | 1.01e-04 | 25 | 126 | 3 | 32238932 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | LEO1 RBM33 PHAX TTC1 WWC2 EPS15L1 PHLDB1 CCDC88A UBR5 EIF4B RWDD1 TMED8 FERMT2 | 1.05e-04 | 1038 | 126 | 13 | 26673895 |
| Pubmed | MYH10 SAAL1 LEO1 PPFIA1 SIPA1L3 ODF2 CASK WWC2 CCDC88A ARL13B ELP2 GOLGA4 KPNB1 | 1.17e-04 | 1049 | 126 | 13 | 27880917 | |
| Pubmed | Myosin II regulates extension, growth and patterning in the mammalian cochlear duct. | 1.29e-04 | 5 | 126 | 2 | 19439495 | |
| Pubmed | 1.29e-04 | 5 | 126 | 2 | 33871354 | ||
| Pubmed | 1.29e-04 | 5 | 126 | 2 | 25906927 | ||
| Pubmed | 1.29e-04 | 5 | 126 | 2 | 19131326 | ||
| Pubmed | 1.29e-04 | 5 | 126 | 2 | 32450252 | ||
| Pubmed | 1.29e-04 | 5 | 126 | 2 | 29244804 | ||
| Pubmed | cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing. | 1.29e-04 | 5 | 126 | 2 | 12839582 | |
| Pubmed | Cell-cell adhesions and cell contractility are upregulated upon desmosome disruption. | 1.29e-04 | 5 | 126 | 2 | 25006807 | |
| Pubmed | 1.29e-04 | 5 | 126 | 2 | 31461656 | ||
| Pubmed | Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics. | 1.29e-04 | 5 | 126 | 2 | 19721433 | |
| Pubmed | RanGTP aids anaphase entry through Ubr5-mediated protein turnover. | 1.29e-04 | 5 | 126 | 2 | 26438829 | |
| Pubmed | Melanophilin directly links Rab27a and myosin Va through its distinct coiled-coil regions. | 1.29e-04 | 5 | 126 | 2 | 12062444 | |
| Pubmed | DBC1 functions as a tumor suppressor by regulating p53 stability. | 1.29e-04 | 5 | 126 | 2 | 25732823 | |
| Pubmed | 1.29e-04 | 5 | 126 | 2 | 18630941 | ||
| Interaction | CTAGE1 interactions | 2.88e-07 | 10 | 125 | 4 | int:CTAGE1 | |
| Interaction | PHF21A interactions | NOL4 HIVEP1 ZGRF1 PPFIA1 ZNF507 INPP5F ANKHD1 RLF CCDC88A UBR5 RABGEF1 SKA3 | 1.54e-06 | 343 | 125 | 12 | int:PHF21A |
| Interaction | CSNK2A1 interactions | MAP9 LEO1 RBM33 FOS ZFC3H1 ANKRD36C VSX1 MDM2 SIRT1 ANKRD36B NMT2 EIF4B HTATSF1 KMT2A MAP3K13 KIF5C ARHGAP18 VAMP4 WDR44 KPNB1 | 1.73e-06 | 956 | 125 | 20 | int:CSNK2A1 |
| Interaction | SFN interactions | EXPH5 PPFIA1 SIPA1L3 TEX14 INPP5F SAMSN1 MDM2 DENND2B WWC2 PHLDB1 CCDC88A EIF4B KMT2A RABGEF1 AKAP13 SKA3 | 6.03e-06 | 692 | 125 | 16 | int:SFN |
| Interaction | HDAC1 interactions | MYH10 HIVEP1 ZGRF1 PPFIA1 ZNF507 INPP5F SAMSN1 RFC1 MDM2 ANKHD1 PALB2 EMSY SIRT1 RLF UBR5 MYH14 KMT2A SKA3 GOLGA4 KPNB1 | 1.55e-05 | 1108 | 125 | 20 | int:HDAC1 |
| Interaction | GAN interactions | 2.90e-05 | 253 | 125 | 9 | int:GAN | |
| Interaction | NUP43 interactions | HIVEP1 LEO1 ASH1L CCDC168 ZFC3H1 RFC1 EMSY RYR2 RLF CCDC88A UBR5 KMT2A EIF4G3 KPNB1 | 3.40e-05 | 625 | 125 | 14 | int:NUP43 |
| Interaction | DYRK1A interactions | MYT1L LEO1 PPFIA1 SIPA1L3 MDM2 ANKHD1 SIRT1 EIF4B LRP4 ELP2 EIF4G3 FERMT2 KPNB1 | 3.95e-05 | 552 | 125 | 13 | int:DYRK1A |
| Interaction | YWHAH interactions | HIVEP1 EXPH5 PPFIA1 SIPA1L3 INPP5F SAMSN1 DENND2B WWC2 PHLDB1 CCDC88A EIF4B KMT2A RABGEF1 AKAP13 KIF5C SKA3 EIF4G3 FERMT2 GOLGA4 | 4.85e-05 | 1102 | 125 | 19 | int:YWHAH |
| Interaction | RAB11A interactions | MYH10 PPFIA1 ITGA2 INPP5F EPS15L1 CCDC88A STX3 ATP11B ARL13B LRP4 RABGEF1 ARHGAP18 VAMP4 FERMT2 GOLGA4 WDR44 | 5.56e-05 | 830 | 125 | 16 | int:RAB11A |
| Interaction | RCOR1 interactions | NOL4 MYH10 HIVEP1 ZGRF1 PPFIA1 LAMB2 ANKHD1 PALB2 RLF CCDC88A UBR5 RABGEF1 | 5.91e-05 | 494 | 125 | 12 | int:RCOR1 |
| Cytoband | 7q35 | 1.66e-05 | 55 | 126 | 4 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 3.42e-05 | 66 | 126 | 4 | chr7q35 | |
| Cytoband | 10q26.11 | 8.74e-04 | 16 | 126 | 2 | 10q26.11 | |
| Cytoband | 11q23.3 | 1.32e-03 | 78 | 126 | 3 | 11q23.3 | |
| Cytoband | 6q23.2 | 2.15e-03 | 25 | 126 | 2 | 6q23.2 | |
| Cytoband | 3q27 | 2.15e-03 | 25 | 126 | 2 | 3q27 | |
| Cytoband | 14q24.3 | 2.19e-03 | 93 | 126 | 3 | 14q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q23 | 3.26e-03 | 220 | 126 | 4 | chr11q23 | |
| GeneFamily | CTAGE family | 8.82e-09 | 15 | 92 | 5 | 907 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 1.37e-04 | 20 | 92 | 3 | 548 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HIVEP1 PPFIA1 INPP5F DENND2B CASK RLF JARID2 DLC1 ATP11B SACS UBR5 NMT2 AKAP13 KIF5C EIF4G3 SETD3 FERMT2 GOLGA4 | 1.53e-07 | 856 | 126 | 18 | M4500 |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP | CTAGE9 NEXMIF TTC39C AFF3 ZNF507 CTAGE6 ANKRD36C CASK ANKRD36B FANCB EIF4B CTAGE15 CTAGE4 WDR44 LARGE1 | 1.56e-07 | 587 | 126 | 15 | M40869 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | HIVEP1 PPFIA1 INPP5F CASK JARID2 DLC1 ATP11B UBR5 NMT2 KIF5C EIF4G3 FERMT2 GOLGA4 | 4.14e-07 | 466 | 126 | 13 | M13522 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MYH10 PPFIA1 RFC1 PHAX TTC1 ANKHD1 RLF CCDC88A SACS RWDD1 HTATSF1 TRPM1 GOLGA4 | 1.72e-05 | 656 | 126 | 13 | M18979 |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_CIRCRNA_GENES | 4.07e-05 | 40 | 126 | 4 | MM17488 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_345_5P_GENES | 4.27e-05 | 80 | 126 | 5 | MM17502 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_MAC_UP | 4.84e-05 | 197 | 126 | 7 | M5401 | |
| Coexpression | GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_DN | 4.99e-05 | 198 | 126 | 7 | M325 | |
| Coexpression | GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_DN | 4.99e-05 | 198 | 126 | 7 | M7265 | |
| Coexpression | GSE3982_MAC_VS_TH1_DN | 5.15e-05 | 199 | 126 | 7 | M5511 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP | 5.32e-05 | 200 | 126 | 7 | M7500 | |
| Coexpression | GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 5.32e-05 | 200 | 126 | 7 | M6997 | |
| Coexpression | TRAVAGLINI_LUNG_BASOPHIL_MAST_1_CELL | 5.87e-05 | 276 | 126 | 8 | M41689 | |
| Coexpression | HEVNER_SUBVENTRICULAR_ZONE_AND_UP_NEURON_FATE_COMMITTED_CELLS | 8.41e-05 | 48 | 126 | 4 | MM409 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN | VWA8 CTC1 SYNE1 TTC39C AFF3 ZNF507 ANKRD36C CASK ANKRD36B SACS UBR5 NMT2 EIF4B KMT2A ELP2 | 1.07e-04 | 1012 | 126 | 15 | M40864 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NOL4 MYH10 SAAL1 SLC4A8 LEO1 ZGRF1 DNAJC21 RFC1 ODF2 PHAX FANCM PALB2 EMSY SIRT1 PKNOX2 JARID2 TRMT6 CCDC88A MYH14 TRPM1 KIF5C KPNB1 | 3.50e-05 | 1459 | 124 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.45e-05 | 219 | 124 | 8 | gudmap_developingGonad_e16.5_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_100 | 4.49e-05 | 34 | 124 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | MYT1L CCDC73 NEXMIF ASH1L DNAJC21 TEX14 INPP5F RYR2 RLF FAM204A STX3 ATP11B SACS NMT2 WDR44 | 6.27e-05 | 795 | 124 | 15 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.28e-05 | 230 | 124 | 8 | gudmap_developingGonad_e18.5_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | 8.35e-05 | 382 | 124 | 10 | gudmap_developingGonad_e14.5_ ovary_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | CCDC73 ZGRF1 DNAJC21 TEX14 PALB2 SIRT1 FANCB ATP11B NMT2 WDR44 | 8.91e-05 | 385 | 124 | 10 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_200 | 9.40e-05 | 78 | 124 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | SAAL1 SLC4A8 RBM33 PPFIA1 ASH1L DNAJC21 ODF2 ANKHD1 CEP164 CCDC88A UBR5 ERCC6L2 KIF5C GOLGA4 KPNB1 | 1.03e-04 | 831 | 124 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | MYH10 SAAL1 SLC4A8 LEO1 ZGRF1 DNAJC21 RFC1 ODF2 PHAX FANCM PALB2 EMSY SIRT1 PKNOX2 JARID2 TRMT6 CCDC88A MYH14 KPNB1 | 1.24e-04 | 1257 | 124 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | MYT1L CCDC73 NEXMIF ASH1L DNAJC21 TEX14 RFC1 RYR2 RLF FAM204A STX3 SACS NMT2 WDR44 | 1.83e-04 | 778 | 124 | 14 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_200 | 1.92e-04 | 49 | 124 | 4 | gudmap_developingGonad_e18.5_ovary_200_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 2.72e-04 | 152 | 124 | 6 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.74e-04 | 361 | 124 | 9 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.91e-04 | 532 | 124 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | ZGRF1 DNAJC21 TEX14 FANCM PALB2 SIRT1 JARID2 FANCB ATP11B UBR5 NMT2 SKA3 SETD3 WDR44 | 3.20e-04 | 822 | 124 | 14 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | MYT1L CACNA1D MYH10 SYNE1 AFF3 MYRIP TENM2 RYR2 ANKRD36B KIF5C | 2.43e-10 | 196 | 126 | 10 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 |
| ToppCell | COPD-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 3.15e-09 | 186 | 126 | 9 | 8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.21e-09 | 197 | 126 | 9 | 61f909737c5f630beffdd326c6844215643dbdde | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 5.95e-09 | 200 | 126 | 9 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.92e-08 | 181 | 126 | 8 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.46e-08 | 191 | 126 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.76e-08 | 192 | 126 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.76e-08 | 192 | 126 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.08e-08 | 193 | 126 | 8 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.08e-08 | 193 | 126 | 8 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.08e-08 | 193 | 126 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 8.08e-08 | 193 | 126 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.41e-08 | 194 | 126 | 8 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.41e-08 | 194 | 126 | 8 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 8.41e-08 | 194 | 126 | 8 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 8.75e-08 | 195 | 126 | 8 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 8.75e-08 | 195 | 126 | 8 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.10e-08 | 196 | 126 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.84e-08 | 198 | 126 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.84e-08 | 198 | 126 | 8 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.84e-08 | 198 | 126 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.99e-07 | 167 | 126 | 7 | 55c3c68af269fcf40f2b080ae4489523609ad388 | |
| ToppCell | Pericytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 9.22e-07 | 183 | 126 | 7 | d04deef7cd4e1738227a6593b84874ce0168c773 | |
| ToppCell | COPD-Stromal-Pericyte|COPD / Disease state, Lineage and Cell class | 9.56e-07 | 184 | 126 | 7 | a56264a22dfc2d3672b20134ab7c3c7c23da5ae1 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 9.91e-07 | 185 | 126 | 7 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.07e-06 | 187 | 126 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.07e-06 | 187 | 126 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.10e-06 | 188 | 126 | 7 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.18e-06 | 190 | 126 | 7 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.18e-06 | 190 | 126 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.18e-06 | 190 | 126 | 7 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-06 | 191 | 126 | 7 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-06 | 191 | 126 | 7 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.23e-06 | 191 | 126 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.27e-06 | 192 | 126 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.32e-06 | 193 | 126 | 7 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.32e-06 | 193 | 126 | 7 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.36e-06 | 194 | 126 | 7 | d8f367beab16a3186821e42311947b6c9e99978c | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.41e-06 | 195 | 126 | 7 | f1f48e2e57b2282572959b152aad4bee05143f03 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.41e-06 | 195 | 126 | 7 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-06 | 195 | 126 | 7 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.41e-06 | 195 | 126 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.41e-06 | 195 | 126 | 7 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 1.46e-06 | 196 | 126 | 7 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | distal-2-Hematologic-Basophil/Mast_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.46e-06 | 196 | 126 | 7 | ad21706a281f0b105eb3979e3e47fe0cec6c527f | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.46e-06 | 196 | 126 | 7 | e08f90f7a923c2846cac859519b8dc7c0ac7cd03 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.46e-06 | 196 | 126 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | IPF-Stromal-Pericyte|IPF / Disease state, Lineage and Cell class | 1.46e-06 | 196 | 126 | 7 | 8b6ff47ce5291d223f5e639fc45cd9267f418256 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.46e-06 | 196 | 126 | 7 | 03710e2a843279124a45a271bffb132835e6081c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.46e-06 | 196 | 126 | 7 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.51e-06 | 197 | 126 | 7 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.51e-06 | 197 | 126 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.51e-06 | 197 | 126 | 7 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-06 | 197 | 126 | 7 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.56e-06 | 198 | 126 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.56e-06 | 198 | 126 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.56e-06 | 198 | 126 | 7 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.56e-06 | 198 | 126 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-Treg|Influenza_Severe / Disease, condition lineage and cell class | 1.56e-06 | 198 | 126 | 7 | e377fa0215f338f86ee2903ce3fa57cea805a630 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.56e-06 | 198 | 126 | 7 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.56e-06 | 198 | 126 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.61e-06 | 199 | 126 | 7 | a24a319d3ba8f4759f742af27610b4d62e359a2d | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.61e-06 | 199 | 126 | 7 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.61e-06 | 199 | 126 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.67e-06 | 200 | 126 | 7 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | Caecum-(7)_Mast_cell|Caecum / shred on region, Cell_type, and subtype | 1.67e-06 | 200 | 126 | 7 | d23fe8644ce42ace51fcde43cb4cd22a99300c02 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-06 | 200 | 126 | 7 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Transverse-(7)_Mast_cell-(70)_Mast|Transverse / shred on region, Cell_type, and subtype | 1.67e-06 | 200 | 126 | 7 | aa17354c83b0967707d995e4b74e042ac211f814 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.67e-06 | 200 | 126 | 7 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | Transverse-Mast_cell-Mast|Transverse / Region, Cell class and subclass | 1.67e-06 | 200 | 126 | 7 | 0af942a33cc50da65129204976e24203320e206d | |
| ToppCell | Transverse-Mast_cell|Transverse / Region, Cell class and subclass | 1.67e-06 | 200 | 126 | 7 | 5e3f5349ffbcabdca3d911fbc99a46aaa56c47c4 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.67e-06 | 200 | 126 | 7 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.67e-06 | 200 | 126 | 7 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-06 | 200 | 126 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.67e-06 | 200 | 126 | 7 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-06 | 200 | 126 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-06 | 200 | 126 | 7 | cb31cfcfa8e6d6cc610c4c22e97bc009dd8a9e7c | |
| ToppCell | Caecum-Mast_cell|Caecum / Region, Cell class and subclass | 1.67e-06 | 200 | 126 | 7 | 8791d0b3d883e7a747a23d21118817f5be4013b6 | |
| ToppCell | Caecum-(7)_Mast_cell-(70)_Mast|Caecum / shred on region, Cell_type, and subtype | 1.67e-06 | 200 | 126 | 7 | 9974285c28a633a010c4f24d035ad3685705e881 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-06 | 200 | 126 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Caecum-Mast_cell-Mast|Caecum / Region, Cell class and subclass | 1.67e-06 | 200 | 126 | 7 | 168426e8296697d05684d71989c4eb5bb2a0489f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-06 | 200 | 126 | 7 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Transverse-(7)_Mast_cell|Transverse / shred on region, Cell_type, and subtype | 1.67e-06 | 200 | 126 | 7 | d90d1d3015a9258298bd6b4ba07971aa1af8b82b | |
| ToppCell | (70)_Mast|World / shred on Cell_type and subtype | 1.84e-06 | 203 | 126 | 7 | b7af2130b4965661b5a50717a7f82d8d498f8d08 | |
| ToppCell | Influenza_Severe-Treg|World / Disease group and Cell class | 4.23e-06 | 149 | 126 | 6 | 3250bb668319139451c31aa496b3ca1ed6750ce4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.51e-06 | 156 | 126 | 6 | 4d2679e7639758c49fc25a2deb9109b08f0a3e57 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.72e-06 | 157 | 126 | 6 | 84f629b7f589ca8a1abc220fa740c4a6fdc1b579 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.15e-06 | 159 | 126 | 6 | ecd1daa33549541aee3bf4e139ab6732efc8e74c | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.15e-06 | 159 | 126 | 6 | 7b6370c9567da7d40541c6e243efa704ed7e90ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.34e-06 | 164 | 126 | 6 | 2c48c6e4eeee845f0563982d0bfa2a176ca5ef61 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 8.43e-06 | 168 | 126 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 176 | 126 | 6 | 533d544852038c0612aacf87f4b1c88ff7aace82 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-05 | 177 | 126 | 6 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-05 | 177 | 126 | 6 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.17e-05 | 178 | 126 | 6 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.33e-05 | 182 | 126 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.46e-05 | 185 | 126 | 6 | 3fafb1d36c5f98a29d20a5ce5192c83d6f603514 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.50e-05 | 186 | 126 | 6 | de55471dd5c842026b409cfebf67fe32f079a011 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.55e-05 | 187 | 126 | 6 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 1.55e-05 | 187 | 126 | 6 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.42e-06 | 198 | 124 | 9 | 6239_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 1.02e-05 | 191 | 124 | 8 | 4283_DN | |
| Drug | Piretanide [55837-27-9]; Up 200; 11uM; HL60; HT_HG-U133A | 1.06e-05 | 192 | 124 | 8 | 6144_UP | |
| Drug | Cytisine (-) [485-35-8]; Down 200; 21uM; MCF7; HT_HG-U133A | 1.27e-05 | 197 | 124 | 8 | 6217_DN | |
| Drug | 1,3,5-triethylbenzene | 1.29e-05 | 9 | 124 | 3 | CID000007602 | |
| Drug | Hydroflumethiazide [135-09-1]; Up 200; 12uM; HL60; HT_HG-U133A | 1.32e-05 | 198 | 124 | 8 | 1851_UP | |
| Disease | Acute monocytic leukemia | 6.28e-08 | 26 | 120 | 5 | C0023465 | |
| Disease | Bone marrow hypocellularity | 7.62e-07 | 18 | 120 | 4 | C1855710 | |
| Disease | Pancytopenia | 3.63e-06 | 26 | 120 | 4 | C0030312 | |
| Disease | Miller Dieker syndrome | 5.71e-06 | 29 | 120 | 4 | C0265219 | |
| Disease | Intellectual Disability | 1.52e-05 | 447 | 120 | 10 | C3714756 | |
| Disease | serum gamma-glutamyl transferase measurement | FOXN2 SLC4A8 SIPA1L3 ASH1L TENM2 DENND2B EMSY RYR2 WWC2 EDAR KMT2A AKAP13 YY1AP1 GOLGA4 | 2.17e-05 | 914 | 120 | 14 | EFO_0004532 |
| Disease | Neurodevelopmental Disorders | 4.00e-05 | 93 | 120 | 5 | C1535926 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 5.93e-05 | 101 | 120 | 5 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | Bone Marrow failure syndromes | 9.79e-05 | 4 | 120 | 2 | C2931245 | |
| Disease | Bone marrow failure syndrome 2 | 9.79e-05 | 4 | 120 | 2 | C3810350 | |
| Disease | Bone marrow failure syndrome 1 | 9.79e-05 | 4 | 120 | 2 | C3808553 | |
| Disease | Fanconi Anemia | 1.41e-04 | 25 | 120 | 3 | C0015625 | |
| Disease | Cerebellar Ataxia | 1.63e-04 | 5 | 120 | 2 | C0007758 | |
| Disease | MYELODYSPLASTIC SYNDROME | 1.64e-04 | 67 | 120 | 4 | C3463824 | |
| Disease | interleukin-8 measurement | 2.71e-04 | 31 | 120 | 3 | EFO_0004811 | |
| Disease | Abnormality of radial ray | 3.27e-04 | 33 | 120 | 3 | C4228778 | |
| Disease | tongue squamous cell carcinoma (is_marker_for) | 4.61e-04 | 37 | 120 | 3 | DOID:0050865 (is_marker_for) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 4.99e-04 | 447 | 120 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | sleep duration | 7.18e-04 | 362 | 120 | 7 | EFO_0005271 | |
| Disease | insulin sensitivity measurement, glucose homeostasis measurement | 7.19e-04 | 43 | 120 | 3 | EFO_0004471, EFO_0006896 | |
| Disease | Leukemia, Myelocytic, Acute | 7.24e-04 | 173 | 120 | 5 | C0023467 | |
| Disease | Prostatic Neoplasms | 9.53e-04 | 616 | 120 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 9.53e-04 | 616 | 120 | 9 | C0376358 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.05e-03 | 12 | 120 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | alcohol and nicotine codependence | 1.24e-03 | 13 | 120 | 2 | EFO_0004776 | |
| Disease | response to cisplatin, platinum measurement | 1.32e-03 | 53 | 120 | 3 | EFO_0010154, GO_0072718 | |
| Disease | Fanconi anemia | 1.45e-03 | 14 | 120 | 2 | cv:C0015625 | |
| Disease | depressive symptom measurement | 1.83e-03 | 426 | 120 | 7 | EFO_0007006 | |
| Disease | proprotein convertase subtilisin/kexin type 7 measurement | 2.14e-03 | 17 | 120 | 2 | EFO_0008270 | |
| Disease | sleep measurement | 2.28e-03 | 135 | 120 | 4 | EFO_0004870 | |
| Disease | magnesium measurement | 2.49e-03 | 66 | 120 | 3 | EFO_0004845 | |
| Disease | Microcephaly | 2.60e-03 | 67 | 120 | 3 | C0025958 | |
| Disease | leukemia (implicated_via_orthology) | 2.68e-03 | 19 | 120 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | smoking status measurement | MYT1L CACNA1D NOL4 SLC4A8 AFF3 RHOT2 VSX1 TENM2 RYR2 DLC1 EIF4G3 SETD3 | 2.75e-03 | 1160 | 120 | 12 | EFO_0006527 |
| Disease | visceral:subcutaneous adipose tissue ratio | 2.94e-03 | 70 | 120 | 3 | EFO_0004767 | |
| Disease | red blood cell density measurement | HIVEP1 DNAH10 AFF3 RFC1 DENND2B WWC2 UBR5 AKAP13 TRAF3IP3 EIF4G3 | 3.21e-03 | 880 | 120 | 10 | EFO_0007978 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.50e-03 | 152 | 120 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | asthma | 3.64e-03 | 751 | 120 | 9 | MONDO_0004979 | |
| Disease | unipolar depression, bipolar disorder | 3.84e-03 | 156 | 120 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | sensory peripheral neuropathy, remission | 3.92e-03 | 23 | 120 | 2 | EFO_0009785, MONDO_0002321 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLSSDEEENEQQAAQ | 371 | P51826 | |
| SQESDLKSQEDDLNR | 486 | Q9UBC2 | |
| EQSLEEFAQAESKDQ | 81 | Q9H2A2 | |
| NQESQELSESLKDSA | 446 | Q9NR48 | |
| ELESSQDIQDVLDAN | 861 | Q2NKJ3 | |
| DTTDDDNLELEVNSQ | 286 | Q8IX94 | |
| DTTDDDNLELEVNSQ | 286 | Q86UF2 | |
| DTTDDDNLELEVNSQ | 286 | P0CG41 | |
| DTTDDDNLELKVNSQ | 286 | A4FU28 | |
| DTTDDDNLELEVNSQ | 286 | A4D2H0 | |
| DNEVEQEDLAQSLSL | 2166 | Q12802 | |
| KEALTQQLKNEDETD | 321 | Q3SXY8 | |
| NNSNQVSETDEKEDL | 931 | Q8N2N9 | |
| ERKNELISQDSDSDS | 1001 | P78524 | |
| ENSGLNLQEDKEDES | 26 | Q9H8W3 | |
| KKNQSDLSDEELNDD | 56 | Q96EV2 | |
| EENLDESTIDNLNKI | 336 | Q16769 | |
| IEKLDAQSLNLSQED | 366 | Q9UJ41 | |
| LSIEEKNENDENSLS | 41 | P0C860 | |
| AQDSDDSEELNIILQ | 61 | Q68G75 | |
| ASEKEEDLSNNNLEA | 451 | Q9HCC9 | |
| NNSNQVSETDEKEDL | 1356 | Q5JPF3 | |
| LNEDESLQRLQKESD | 866 | O14936 | |
| SDQSDDEKIQNSDDE | 151 | Q8WVC0 | |
| ERAQGSDEDKLQNSD | 166 | Q8WVC0 | |
| NSENLQKQLSELDED | 426 | O95461 | |
| EEITENHNSLKSDEN | 271 | Q49MG5 | |
| ESAASQQSLELDDQD | 6 | O60551 | |
| QAETDQLEDEKSALQ | 166 | P01100 | |
| KLNLKESDDSVNTED | 576 | Q8NI17 | |
| ELESSLEKSLQENKN | 571 | Q13439 | |
| TKSENDASSENEQLL | 266 | Q9UNE0 | |
| NEQDSSLLDFLNDET | 1536 | Q8IYD8 | |
| EETNIDEASENTKSN | 361 | Q53TS8 | |
| AETTANELLDNDSEK | 396 | Q53TS8 | |
| SLEKENSQLDEENLE | 691 | Q3V6T2 | |
| ENKSLEQETSQLEKD | 816 | Q3V6T2 | |
| DTQDETQKSDLENED | 681 | Q86VH2 | |
| ELEDTLDSTNAQQEL | 1171 | Q7Z406 | |
| DTTLLDLQNNDISEL | 91 | P21810 | |
| DLNDKLENEIANKDS | 341 | Q13136 | |
| KDLNESISEEDKQLS | 701 | Q8NEV8 | |
| LTQLEADLTDVQDEN | 1276 | P55268 | |
| KSLQENRSSEDTQDE | 76 | A0A087WXM9 | |
| DTNLNQDSAKELEDS | 416 | Q5F1R6 | |
| DSQEDSKENLSQEES | 316 | Q13316 | |
| QALSESQEENKADNL | 911 | P17301 | |
| DEKLSDNFQDSEQLV | 461 | Q8NB91 | |
| NVLDKELEENDSENS | 586 | O43719 | |
| DASKNLNLSNEETDQ | 446 | Q86YC2 | |
| LLENAQSSEKTEENE | 766 | O43283 | |
| NSDQTKADLDSSLDI | 621 | Q6ZRK6 | |
| LENKLQEEEEESNTS | 501 | Q9UPI3 | |
| LTQTLTKQDENDDDD | 326 | Q14974 | |
| LVDSESADDELTNLN | 46 | P32314 | |
| TELLKSDSDNNNSDD | 2826 | Q03164 | |
| LELNNFTSQQLDDEE | 1281 | Q7Z589 | |
| ETQDDDNIRLKENTF | 246 | Q6IA86 | |
| EGNESQNTLDAKLQD | 1186 | Q8NDH2 | |
| DILNEQNDESLSKLT | 1491 | Q5T890 | |
| TSENHLNNSDKEVDE | 331 | Q96AC1 | |
| LSTRAKDQNESLDEE | 656 | Q96AC1 | |
| DESDLSENEKTNDTL | 201 | Q8IXS0 | |
| ETSENKNLLKDLEDS | 3581 | Q8IVF4 | |
| NTKSSSDDEEQLTEL | 51 | Q96ER3 | |
| NSKSDEDRQLANSLE | 866 | Q9Y2H2 | |
| LKSDQDLSEQESKQN | 1341 | Q9NZJ4 | |
| ISESDLNERSANKEE | 4206 | Q92736 | |
| SSKDLLDNQSQEEQR | 1156 | O43432 | |
| TQVNLDLTSLLDNED | 271 | Q96KN3 | |
| EDDSNSTNHNLEKVE | 151 | Q01668 | |
| QNELDNVSTLLEEAE | 1286 | P35580 | |
| QAIKSLNFQEDDDTS | 336 | Q9H814 | |
| ESEKSLENETLNKEE | 441 | P23588 | |
| EQSENEKDDASQVSS | 76 | Q92833 | |
| LQDLKDRLEQSESTN | 776 | Q5BJF6 | |
| SLLDDSQENQKSLEQ | 1826 | Q86VV8 | |
| LDELQDKSESLSDNA | 81 | O75379 | |
| ANDQRHLEEQETDSK | 1366 | Q8IWB6 | |
| ESDLIEKDLNDALQN | 1901 | Q8NF91 | |
| QLEESQDSLSEELAK | 656 | O60282 | |
| SDQDLDQALSDEELN | 196 | Q8IXI1 | |
| DQALSDEELNAFQKS | 201 | Q8IXI1 | |
| RKELSQNTDESGLND | 186 | P35251 | |
| NLADDSSENKVENLL | 571 | P35251 | |
| NSDNGKEDLESENLS | 346 | Q9NSI8 | |
| ENTLINGVKENDSED | 16 | Q5QGS0 | |
| DQIDTLTSDLQLEDE | 56 | Q569H4 | |
| EENDDKITQASQSQE | 376 | Q00987 | |
| LKLEAELDTEANSNE | 81 | Q96LK8 | |
| ENESLNQESKRAVED | 566 | Q86TU7 | |
| STEDLNCKENLEQDL | 401 | O60292 | |
| LDQAAKSNDDLDVSE | 556 | Q96EB6 | |
| ALTLTDSDNENKSDD | 151 | Q9NT68 | |
| SDLILDQQELSSDLN | 191 | Q2Y0W8 | |
| SSDEEDSVAKNRDLQ | 1381 | Q9ULL5 | |
| KLDQLDQDIENALST | 361 | Q96QB1 | |
| LLNSQQDEDESSIES | 206 | O94818 | |
| EQLKAKQLTQDDDTD | 6 | Q13277 | |
| DQKSQCQLIDSSEDL | 666 | Q9UL12 | |
| TILFKDNDVDDEQQS | 901 | Q8IWZ3 | |
| IEDKDDSQSSQDELQ | 446 | Q9UPV0 | |
| EESDQKAQVNTSDLN | 381 | Q9Y2G3 | |
| NKSEEAIDTESRLND | 246 | Q8IX90 | |
| SDEDSQSEDRNDLKA | 141 | Q9NZR4 | |
| VDQDDDQDSSSLKLS | 186 | Q8ND24 | |
| DTQDLQDQLKRSEAE | 391 | Q9Y228 | |
| LVDKETNTDEAANDN | 961 | Q6AWC2 | |
| AKVTNSDNEDLLQEL | 106 | Q8NB66 | |
| DTETAENLKENSDSN | 881 | Q13129 | |
| ENLKENSDSNSSDQL | 886 | Q13129 | |
| SKQEEDNTQSDDILE | 231 | Q14515 | |
| VSNDAAQSDDEEKLQ | 396 | Q5JSH3 | |
| KNSITEISDNEDDLL | 576 | Q86UU1 | |
| ELENIKKSSENSQED | 81 | Q8N392 | |
| LVDDISQDLDNNSKD | 661 | Q7Z4N2 | |
| TLEEKQASEQENEDS | 291 | Q9UJA5 | |
| EINSDQGLEKDNSEL | 406 | Q9H869 | |
| NASDDDILKELQDNA | 601 | Q8TCN5 | |
| EDDVNSNLKDLSLQK | 356 | Q86YA3 | |
| DTEEESQESNKISQD | 541 | Q86YA3 | |
| GESDIENLDNKEIQS | 841 | Q01118 | |
| TENELDQADKELENT | 546 | Q6R2W3 | |
| AQNTLLESLDEDNSA | 716 | Q5QJ38 | |
| KLTEESLTSDAANDN | 186 | Q8N584 | |
| SQENLEDNDVSDILK | 71 | Q9H446 | |
| NLADATIEINTDDNL | 701 | A3KMH1 | |
| NKSNEDVNSSELDEE | 81 | Q99614 | |
| DKTLQELEELQNDSE | 6 | A5D8V6 | |
| DLTQDKLTLDTEEND | 1016 | O60293 | |
| KDASEINSEQDKENS | 2041 | P15822 | |
| AAASENEDLENKDTS | 36 | Q6PL24 | |
| NEDLENKDTSLLASA | 41 | Q6PL24 | |
| DDTNQSATLNDKDDD | 1996 | O95071 | |
| SLDDTETEQLLQEEQ | 1856 | O75096 | |
| TESENQKESLSSEDN | 611 | Q8NFW9 | |
| NSLEDDSDKNENLGR | 231 | Q9UL68 | |
| KQLDEEIKELNESNS | 1066 | Q9UL68 |